Loading
Only a handful of insider records exist for Lotus Biotech Development Corp., the last one from 6 October 2016, too few to describe a trend. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
4 of 4 declarations
Lotus Biotech Development Corp. is a company focused on biotechnology development. It is listed on the XNAS market.